Literature DB >> 29872466

Navigated Laser Therapy for Diabetic Macular Oedema.

Marcus Kernt1, Michael Ulbig1, Anselm Kampik2, Aljoscha S Neubauer1.   

Abstract

Navigated laser therapy introduces computerised assistance systems to retinal laser photocoagulation treatment. Some of the main benefits the Navilas system offers over conventional laser include high precision and safety and provides additional advantages in terms of standardisation of planning, execution, documentation, quality assurance and better overall treatment comfort for the patient. Navigated laser therapy is being used with good success in the treatment of diabetic macular oedema (DMO), retinal vein occlusions (RVO) and fastpattern navigated panretinal photocoagulation in proliferative diabetic retinopathy (PDR). In centre-involving DMO, a combination of anti-vascular endothelial growth factor (VEGF) and macular laser may provide advantages over anti-VEGF monotherapy. In terms of navigated laser therapy, recent study data from our clinic and other institutions indicate that combined initial anti-VEGF and navigated macular laser therapy allows treatment success to be achieved and maintained with a significantly reduced number of interventions.

Entities:  

Keywords:  Diabetic retinopathy; ETDRS; diabetes; macular oedema; navigated laser therapy; pattern laser

Year:  2014        PMID: 29872466      PMCID: PMC5983099          DOI: 10.17925/EE.2014.10.01.66

Source DB:  PubMed          Journal:  Eur Endocrinol        ISSN: 1758-3772


  24 in total

1.  [Navigated focal retinal laser therapy using the NAVILAS® system for diabetic macula edema].

Authors:  M Kernt; R Cheuteu; R G Liegl; F Seidensticker; S Cserhati; C Hirneiss; C Haritoglou; A Kampik; M Ulbig; A S Neubauer
Journal:  Ophthalmologe       Date:  2012-07       Impact factor: 1.059

2.  Focal navigated laser photocoagulation in retinovascular disease: clinical results in initial case series.

Authors:  Igor Kozak; Jae Suk Kim; Stephen F Oster; Jay Chhablani; William R Freeman
Journal:  Retina       Date:  2012-05       Impact factor: 4.256

Review 3.  Diabetic macular oedema: physical, physiological and molecular factors contribute to this pathological process.

Authors:  Rita Ehrlich; Alon Harris; Thomas A Ciulla; Nisha Kheradiya; Diana M Winston; Barbara Wirostko
Journal:  Acta Ophthalmol       Date:  2010-03-11       Impact factor: 3.761

4.  Clinical evaluation and treatment accuracy in diabetic macular edema using navigated laser photocoagulator NAVILAS.

Authors:  Igor Kozak; Stephen F Oster; Marco A Cortes; Dennis Dowell; Kathrin Hartmann; Jae Suk Kim; William R Freeman
Journal:  Ophthalmology       Date:  2011-01-26       Impact factor: 12.079

5.  Epidemiology of severe hypoglycemia in the diabetes control and complications trial. The DCCT Research Group.

Authors: 
Journal:  Am J Med       Date:  1991-04       Impact factor: 4.965

6.  The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema.

Authors:  Paul Mitchell; Francesco Bandello; Ursula Schmidt-Erfurth; Gabriele E Lang; Pascale Massin; Reinier O Schlingemann; Florian Sutter; Christian Simader; Gabriela Burian; Ortrud Gerstner; Andreas Weichselberger
Journal:  Ophthalmology       Date:  2011-04       Impact factor: 12.079

7.  Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema.

Authors:  Michael J Elman; Neil M Bressler; Haijing Qin; Roy W Beck; Frederick L Ferris; Scott M Friedman; Adam R Glassman; Ingrid U Scott; Cynthia R Stockdale; Jennifer K Sun
Journal:  Ophthalmology       Date:  2011-04       Impact factor: 12.079

8.  Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group.

Authors: 
Journal:  Arch Ophthalmol       Date:  1985-12

9.  Increased retinal oxygen supply following pan-retinal photocoagulation and vitrectomy and lensectomy.

Authors:  E Stefansson; M B Landers; M L Wolbarsht
Journal:  Trans Am Ophthalmol Soc       Date:  1981

10.  Navigated macular laser decreases retreatment rate for diabetic macular edema: a comparison with conventional macular laser.

Authors:  Aljoscha S Neubauer; Julian Langer; Raffael Liegl; Christos Haritoglou; Armin Wolf; Igor Kozak; Florian Seidensticker; Michael Ulbig; William R Freeman; Anselm Kampik; Marcus Kernt
Journal:  Clin Ophthalmol       Date:  2013-01-16
View more
  2 in total

Review 1.  Emerging Concepts in the Treatment of Diabetic Retinopathy.

Authors:  Michael Patrick Ellis; Daniella Lent-Schochet; Therlinder Lo; Glenn Yiu
Journal:  Curr Diab Rep       Date:  2019-11-20       Impact factor: 4.810

2.  Outcomes of combined treatments in patients with retinal arterial macroaneurysm.

Authors:  Chenghu Wang; Guofan Cao; Xiangzhong Xu; Jian Wang; Shu Zhang
Journal:  Indian J Ophthalmol       Date:  2021-12       Impact factor: 1.848

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.